补充因子H通过JAK2/STAT3信号通路促进肺腺癌细胞的生长
Kaili Wang1,2, Xitan Wang3, Jiang Li2,4
1Laboratory of Thoracic Surgery, Department of Thoracic Surgery, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
Current cancer drug targets
|January 6, 2025
概括
补充因子H (CFH) 通过激活JAK2/STAT3通路来促进肺腺癌的生长. 阻止STAT3酸化抑制了这种效果,这表明CFH是潜在的抗瘤标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 在超过50%的肺腺癌患者中观察到高补充因子H (CFH) 表达.
- 以前的研究表明,CFH抑制了内皮细胞迁移.
研究的目的:
- 研究CFH在肺腺癌发育中的机制.
- 探索STAT3酸化在CFH介导作用中的作用.
主要方法:
- 在CFH基因诱导后使用C57小鼠进行体内研究,这些小鼠患有易斯肺癌瘤.
- 在体外实验中,A549肺腺癌细胞接受了CFH过度表达条件介质的治疗.
- 细胞活力,迁移和JAK2/STAT3酸化水平的评估.
- 使用STATTIC抑制STAT3酸化.
主要成果:
- 在体内,CFH显著促进了肺腺癌的生长.
- CFH条件介质增加了A549细胞活力和迁移.
- 在A549细胞中,CFH治疗增加了JAK2和STAT3酸化.
- 阻断STAT3酸化消除了CFH条件介质对细胞活力和迁移的影响.
结论:
- CFH通过JAK2/STAT3信号通路促进肺腺癌细胞的增殖和迁移.
- 在肺腺癌中,CFH代表了抗瘤策略的潜在治疗标.
相关概念视频
The JAK-STAT Signaling Pathway
8.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K


